NextCure Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Okay. Hello, everyone, and welcome to Day 3 of the 2021 Bank of America Healthcare Conference. Thank you for joining this session with NextCure. My name is Alec Stranahan, and I'm the analyst covering NextCure here at BofA. I'm pleased to be joined with -- today, I'm joined by Michael Richman, President and CEO of NextCure. And I believe Michael has some few slides to start, and then we can jump into Q&A at this time. So with that, Michael, over to you.
Great. Well, thank you very much, Alec, and thank you very much for the opportunity to speak at the BofA Securities Conference. It's a pleasure to give you a quick update on NextCure. So hopefully, everyone has the slides in front of them.
The first slide really addresses the key vision for the organization, and this involves developing next-generation immuno medicines. On Slide 2 is our forward-looking statements.
On Slide 3, these are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
